Liposomal T cell engager and re-director for tumor cell eradication in cancer immunotherapy

T cells are one of the most important effector cells in cancer immunotherapy. Various T cell-dependent bispecific antibody (TDB) drugs that engage T cells for targeted cancer cell lysis are being developed. Here, we describe supra-molecular T-cell redirecting antibody fragment-anchored liposomes (TR...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Fang, Zhang, Luchen, Shi, Sanyuan, Zheng, Anjie, Di, Jiaxing, Jin, Shanshan, Miao, Xuguang, Wu, Fenglan, Chen, Xiaolong, Zhang, Yanhong, Wei, Xiaohui, Xu, Yuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450900/
https://www.ncbi.nlm.nih.gov/pubmed/36041060
http://dx.doi.org/10.1080/19420862.2022.2115205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450900/
https://www.ncbi.nlm.nih.gov/pubmed/36041060
http://dx.doi.org/10.1080/19420862.2022.2115205

Ejemplares similares